The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients

NACompletedINTERVENTIONAL
Enrollment

1,900

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 1997

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

Trial Locations (14)

10037

Harlem AIDS Treatment Group / Harlem Hosp Ctr, New York

19107

Philadelphia FIGHT, Philadelphia

20422

Veterans Administration Med Ctr / Regional AIDS Program, Washington D.C.

23298

Richmond AIDS Consortium, Richmond

30308

AIDS Research Consortium of Atlanta, Atlanta

48201

Comprehensive AIDS Alliance of Detroit, Detroit

48202

Henry Ford Hosp, Detroit

60657

AIDS Research Alliance - Chicago, Chicago

70112

Louisiana Comm AIDS Rsch Prog / Tulane Univ Med, New Orleans

94110

Community Consortium of San Francisco, San Francisco

802044507

Denver CPCRA / Denver Public Hlth, Denver

972109951

Portland Veterans Adm Med Ctr / Rsch & Education Grp, Portland

08103

Southern New Jersey AIDS Cln Trials / Dept of Med, Camden

071032842

North Jersey Community Research Initiative, Newark

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000861 - The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients | Biotech Hunter | Biotech Hunter